tiprankstipranks
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
US Market

Vincerx Pharma Inc (VINC) Stock Price & Analysis

96 Followers

VINC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.63 - $1.95
Previous Close$0.63
Volume137.04K
Average Volume (3M)49.26K
Market Cap
$14.11M
Enterprise Value-$3.93M
Total Cash (Recent Filing)$20.80M
Total Debt (Recent Filing)$2.77M
Price to Earnings (P/E)-0.3
Beta0.91
Mar 26, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.30
Shares Outstanding21,380,570
10 Day Avg. Volume80,617
30 Day Avg. Volume49,263
Standard Deviation0.24
R-Squared0.00111
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.90
Price to Sales (P/S)45.04
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit-13.09
Enterprise Value/Ebitda0.10
Forecast
Price Target Upside515.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1

Financials

Annual

Ownership Overview

3.00% Mutual Funds
25.51% Other Institutional Investors
71.49% Public Companies and
Individual Investors

VINC FAQ

What was Vincerx Pharma Inc’s price range in the past 12 months?
Vincerx Pharma Inc lowest stock price was $0.63 and its highest was $1.95 in the past 12 months.
    What is Vincerx Pharma Inc’s market cap?
    Currently, no data Available
    When is Vincerx Pharma Inc’s upcoming earnings report date?
    Vincerx Pharma Inc’s upcoming earnings report date is Mar 26, 2024 which is in 106 days.
      How were Vincerx Pharma Inc’s earnings last quarter?
      Vincerx Pharma Inc released its earnings results on Nov 14, 2023. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.457 by -$0.003.
        Is Vincerx Pharma Inc overvalued?
        According to Wall Street analysts Vincerx Pharma Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vincerx Pharma Inc pay dividends?
          Vincerx Pharma Inc does not currently pay dividends.
          What is Vincerx Pharma Inc’s EPS estimate?
          Vincerx Pharma Inc’s EPS estimate is -$0.37.
            How many shares outstanding does Vincerx Pharma Inc have?
            Vincerx Pharma Inc has 21,380,570 shares outstanding.
              What happened to Vincerx Pharma Inc’s price movement after its last earnings report?
              Vincerx Pharma Inc reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.457. Following the earnings report the stock price went down -9.091%.
                Which hedge fund is a major shareholder of Vincerx Pharma Inc?
                Among the largest hedge funds holding Vincerx Pharma Inc’s share is Baker Bros Advisors LP. It holds Vincerx Pharma Inc’s shares valued at N/A.
                  ---

                  Vincerx Pharma Inc Stock Smart Score

                  Company Description

                  Vincerx Pharma Inc

                  LifeSci Acquisition Corp is a blank check company.
                  ---

                  Top 5 ETFs holding VINC

                  Name
                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  $308.92K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold VINC. The ETFs are listed according to market value of VINC within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Moderna
                  GlaxoSmithKline
                  BioNTech SE
                  Novavax
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis